SCHEMBL27631997

SCHEMBL27631997

COc1c(N)cccc1-c1ccccc1.Nc1nc(N)c(F)c(-c2cccc(O)c2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 7/20 0.46
▸ ADORA1 P30542 6/20 0.46
▸ ADORA2B P29275 2/20 0.46
▸ PIK3CD O00329 2/20 0.44
▸ PIK3CA P42336 2/20 0.44
▸ PIK3CB P42338 2/20 0.44
▸ PIK3CG P48736 2/20 0.44
▸ PIK3C2B O00750 1/20 0.44
▸ PDXK O00764 1/20 0.44
▸ GAK O14976 1/20 0.44
▸ MAP3K7 O43318 1/20 0.44
▸ RIPK2 O43353 1/20 0.44
▸ PIP5K1C O60331 1/20 0.44
▸ STK16 O75716 1/20 0.44
▸ PIK3C2G O75747 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ OXSR1 O95747 1/20 0.44
▸ LATS1 O95835 1/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ EGFR P00533 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27631865 0.89 ADORA2A (0.51) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL27612430 0.87 ADORA2A (0.47) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL1116418 0.82 PIK3CG (0.60) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL27631994 0.77 DHFR (0.50) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL27631996 0.76 DCPS (0.48) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL3791228 0.74 ALDH1A1 (0.56) MTORCSNK1A1CLK4DYRK1BFYN
SCHEMBL27612968 0.73 PIK3CG (0.50) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL27631918 0.72 PIK3CG (0.64) ADORA2AADORA1ADORA2BPIK3CDPIK3CA
SCHEMBL27631757 0.71 ADORA2A (0.49) ADORA2AADORA1ADORA2BPIK3CGMTOR
SCHEMBL27612323 0.71 CSNK1A1 (0.55) ADORA2AADORA1ADORA2BPIK3CGMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 — — CN disclosed
Send feedback